Explore the vast range of titles available.

Assessing accuracy in CAD-CAM mandibular reconstruction poses significant challenges but is essential for ensuring reliable outcomes. Existing methods are often operator-dependent, lacking repeatability and reproducibility. This study introduces the Global Positioning Layout (GPL) method, an accuracy assessment technique integrated into the reconstruction protocol based on CAD-CAM and additive printing technology. We describe its methodology and present its implementation through an automated workflow. Key principles of accuracy assessment were identified and structured as Requirements, Data input, Data reference system, and Data output. The necessary 3D virtual models were defined: planned mandible, reference mandible, patient-specific implant (PSI), postoperative mandible, and postoperative PSI. A unique coordinate system (GPL-RS) was built on the reference mandible. Three Roto-Translational Matrices (RTMs) were applied to measure movements and deviations between the designed and postoperative models to assess reconstruction accuracy. Five clinical cases with different operational diseases and defects were analysed, comparing spatial deviations between manual and automated methods. The GPL method represents a promising advancement in assessing the accuracy of CAD-CAM reconstructions, providing valuable insights that can improve surgical outcomes.

The lack of a standardized methodology complicates accuracy assessment in computer-assisted mandibular reconstruction. Existing landmark-based methods are susceptible to operator variability, while surface-based comparisons can mask local deviations. This study validates a novel, automated protocol, the Global Positioning Layout (GPL), to quantify the 3D discrepancy between the virtual surgical plan and the postoperative outcome, by comparing its performance and reliability against Methods A and B. A retrospective cohort of 17 patients was analysed, with three operators performing all measurements on two occasions. The GPL method demonstrated complete reproducibility, with no inter- or intra-operator variability, providing a detailed, spatially-oriented assessment of deviations. In contrast, the landmark-based method showed poor reproducibility and systematic bias and was often inapplicable due to the absence of landmarks after resection. The surface-based method, while objective for its mean error metric, was operator-dependent for initial alignment and its non-directional output masked significant localized deviations. This study validates GPL as a robust and fully reproducible tool that overcomes the critical limitations of established techniques. The GPL method provides a strong foundation for a standardized protocol, essential for the reliable comparison of surgical outcomes, refinement of surgical techniques, and improvement of long-term patient outcomes.

Denosumab has proved effective at low doses in increasing bone mineral density in osteoporosis patients. In contrast to high-doses antiresorptive therapy, denosumab has a transient effect on the inhibition of the bone remodeling process, suggesting that denosumab-related osteonecrosis is a self-limiting disease, with a high curative potential of surgery when performed after a proper duration of receptor activator of nuclear factor-kB ligand (RANKL) inhibitor suspension. We report the long-term clinical and radiological (Computed Tomography—CT scan) data of a patient affected by secondary osteoporosis (cancer treatment-induced bone loss—CTIBL for metastatic breast cancer) who underwent surgical treatment for stage II denosumab-related osteonecrosis of the upper maxilla 7 months after denosumab suspension. A minimally invasive approach was performed with the extraction of the first right upper molar and debridement of the surrounding alveolar bone. After surgery, the patient was followed up at three-month intervals up to 1 year, and clinical and radiological data (CT scan) were recorded at each follow-up for the early detection of signs of recurrent disease. The mucosal healing remained stable in the long term, with radiological signs of bone remodeling in the post-operative site since the 6-month follow-up. The presented case strengthens the hypothesis that denosumab induces temporary alterations of bone turnover with a predictable curative effect of minimal surgical procedures in cases of denosumab-related osteonecrosis of the jaw.

A female patient with non-small-cell lung cancer presented with a huge area of exposed bone in the mandible following spontaneous teeth loss. She was receiving multimodal chemotherapy containing bevacizumab. No previous treatment with bisphosphonates or comorbid conditions was reported. Pain medications and infection control were offered to the patient who was closely followed up. Initial imaging and histology of bone and surrounding mucosa (8 weeks after bevacizumab cessation) confirmed the clinical suspicion of avascular osteonecrosis of the mandible. Subsequent imaging and histology of bone and gingiva (12 weeks after bevacizumab cessation) revealed the initial sequestration of the mandible with a marked expansion of the mucosal vascular network. Spontaneous bone sequestration eventually occurred few months later, followed by stable and painless mucosal coverage of the mandibular bone. The patient remained disease-free up to 3 years of follow-up.

The objective of this work was to provide pilot data on feasibility of using virtual reality (VR) to train undergraduate students in pediatric emergency scenarios. We staged VR sessions for a total of 45 medical and nursing students; in every session, each student managed two pediatric emergency virtual scenarios. At the end of the sessions, students completed a Technology Assessment Questionnaire to evaluate the perceived usefulness and perceived ease-of-use of their VR training experience and rated their perceived level of competence in managing the two clinical scenarios. The median perceived usefulness was 91.7/100 (interquartile range (IQR) 80.6–100), while the median perceived ease-of-use was 77.8/100 (IQR 63.9–88.9). The perceived level of competence increased from 2 (IQR 1–3) to 4 (IQR 3–4) on a 5-point Likert scale, for both scenarios ( p  < 0.001, Wilcoxon test for paired samples).        Conclusions : The staged VR sessions had a good perceived usefulness and resulted in an increase in the perceived level of competence. The results on the ease-of-use, however, show that an assumption that millennials and younger students can navigate with confidence VR hardware in a healthcare training setting should not be made; further work is required to ease the integration of VR into curricula. What is Known: • Virtual reality (VR) is a rising simulation training methodology in Pediatric Emergency Medicine (PEM), however little experience is reported about its use for undergraduate students What is New: • VR PEM trainiing was found useful by undergraduate students and its use increased their perceived level of competence, although ease-of-use received lower ratings. • Despite the young age, an assumption that millennials and younger students can navigate with confidence VR hardware in a healthcare training setting should not be made

AimsAmeloblastoma is a rare odontogenic tumour with an aggressive local behaviour. Mutations in the mitogen-activated protein kinase pathway, namely BRAF V600E mutations, are a common finding. To date, there is no clear correlation between BRAF V600 mutation and clinical outcome.MethodsWe retrospectively reviewed the medical records of patients who underwent surgery for ameloblastoma between May 1998 and June 2018, at 11 participating Italian centres. BRAF mutational status was evaluated by quantitative PCR/pyrosequencing. The primary end points were to determine BRAF mutational status in primitive and recurrent ameloblastoma, and to assess the relapse-free interval (RFI); the secondary end point was to investigate the correlation of BRAF mutational status with the clinical features of the tumour and survival outcomes.ResultsOverall, 74 patients were included: 33 (44.5%) were BRAF wild type and 41 (55.4%) BRAF V600 mutated. BRAF V600 mutated ameloblastomas occurred more frequently in younger patients (p=0.0031), were located at the mandible (p=0.0009) and presented with unicystic variant. After a median follow-up of 60 months, 21 (28.3%) patients relapsed (30.3% and 26.8% in the BRAF wild type and BRAF mutated group, respectively). At univariable Cox models, none of the investigated variables, including microscopic margin involvement, was associated with RFI.ConclusionsLocal recurrence occurs in 30% of patients with ameloblastoma. BRAFV600 mutation is associated with younger age, mandibular localisation and with unicystic ameloblastoma. Neither BRAF mutation nor microscopically positive surgical margins were associated with RFI. Further studies are needed to elucidate outcomes of this rare disease according to clinical, histopathological and comprehensive molecular features.

A female patient with non-small-cell lung cancer presented with a huge area of exposed bone in the mandible following spontaneous teeth loss. She was receiving multimodal chemotherapy containing bevacizumab. No previous treatment with bisphosphonates or comorbid conditions was reported. Pain medications and infection control were offered to the patient who was closely followed up. Initial imaging and histology of bone and surrounding mucosa (8 weeks after bevacizumab cessation) confirmed the clinical suspicion of avascular osteonecrosis of the mandible. Subsequent imaging and histology of bone and gingiva (12 weeks after bevacizumab cessation) revealed the initial sequestration of the mandible with a marked expansion of the mucosal vascular network. Spontaneous bone sequestration eventually occurred few months later, followed by stable and painless mucosal coverage of the mandibular bone. The patient remained disease-free up to 3 years of follow-up.

ObjectiveRheumatoid arthritis (RA) is the most common form of inflammatory arthritis and primarily affects the joints. While therapeutic advances have substantially reduced the risk of long-term disability, concerns remain regarding disease-related morbidity. Therefore, we aimed to evaluate incidence, prevalence, mortality rates (MRs), standardised mortality ratios (SMRs) and causes of death in RA in north-eastern Italy from 2012 to 2020.MethodsA retrospective population-based study was conducted in the Veneto region (4.8 million residents) using linked data from the population registry, healthcare co-payment exemptions, hospital discharge records and mortality data. Prevalence and incidence rates were stratified by age and sex. SMRs were calculated by comparing patients with RA to the general population. Causes of death were classified by the International Classification of Diseases Tenth Revision (ICD-10).ResultsWe identified 37 996 patients with RA (prevalence 0.54%) and 12 875 incident cases (incidence rate 33.1/100 000). Incidence was twice as high in females. Among prevalent cases, 7 435 deaths occurred (MR 32.2/1000), while among incident cases there were 1288 deaths over the 8-year study period (MR 21.3/1000). The median age at death was 83 (77–88) years. The overall SMR was 1.28 (95% CI 1.21 to 1.35), higher in patients under 45 years of age (2.15, 95% CI 0.93 to 4.24). Leading causes of death were cardiovascular diseases (37.1%), cancer (20.6%) and infections (10.9%).ConclusionsThis study provides updated data on epidemiology and mortality of RA in Italy, offering insights for healthcare planning and resource allocation. The analysis of causes of death provides additional perspectives for a multidimensional approach to disease management.